Oxygen Therapy for Retinal Ischemia



Status:Enrolling by invitation
Conditions:Peripheral Vascular Disease, Ocular
Therapuetic Areas:Cardiology / Vascular Diseases, Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:12/8/2018
Start Date:November 30, 2018
End Date:January 1, 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Normobaric Nocturnal Hyperoxia Therapy for Treating Ischemic-Related Retinal Conditions

The investigators will be using nocturnal normobaric hyperoxia therapy in patients with
diagnoses of conditions related to retinal ischemia.

Patients who receive a diagnosis of a condition relate to retinal ischemia and who pass the
eligibility criteria will receive an oxygen concentrator to use at home. They will report
back in follow up monthly for three to six months.

Inclusion Criteria:

- Diagnosis of retinal-ischemia related condition

Exclusion Criteria:

- Complicating other ocular condition

- History of smoking or lung conditions
We found this trial at
1
site
Beth Israel Deaconess Medical Center
330 Brookline Ave
Boston, Massachusetts 02215
617-667-7000
Principal Investigator: Jorge Arroyo, MD, MPH
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
?
mi
from
Boston, MA
Click here to add this to my saved trials